MR imaging in discriminating between benign and malignant paediatric ovarian masses: a systematic review.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 06 06 2019
accepted: 08 08 2019
revised: 03 08 2019
pubmed: 19 9 2019
medline: 5 6 2020
entrez: 19 9 2019
Statut: ppublish

Résumé

The use of magnetic resonance (MR) imaging in differentiation between benign and malignant adnexal masses in children and adolescents might be of great value in the diagnostic workup of sonographically indeterminate masses, since preserving fertility is of particular importance in this population. This systematic review evaluates the diagnostic value of MR imaging in children with an ovarian mass. The review was made according to the PRISMA Statement. PubMed and EMBASE were systematically searched for studies on the use of MR imaging in differential diagnosis of ovarian masses in both adult women and children from 2008 to 2018. Sixteen paediatric and 18 adult studies were included. In the included studies, MR imaging has shown good diagnostic performance in differentiating between benign and malignant ovarian masses. MR imaging techniques including diffusion-weighted imaging (DWI) and dynamic contrast-enhanced (DCE) imaging seem to further improve the diagnostic performance. The addition of DWI with apparent diffusion coefficient (ADC) values measured in enhancing components of solid lesions and DCE imaging may further increase the good diagnostic performance of MR imaging in the pre-operative differentiation between benign and malignant ovarian masses by increasing specificity. Prospective age-specific studies are needed to confirm the high diagnostic performance of MR imaging in children and adolescents with a sonographically indeterminate ovarian mass. • MR imaging, based on several morphological features, is of good diagnostic performance in differentiating between benign and malignant ovarian masses. Sensitivity and specificity varied between 84.8 to 100% and 20.0 to 98.4%, respectively. • MR imaging techniques like diffusion-weighted imaging (DWI) and dynamic contrast-enhanced (DCE) imaging seem to improve the diagnostic performance. • Specific studies in children and adolescents with ovarian masses are required to confirm the suggested increased diagnostic performance of DWI and DCE in this population.

Identifiants

pubmed: 31529256
doi: 10.1007/s00330-019-06420-4
pii: 10.1007/s00330-019-06420-4
pmc: PMC6957553
doi:

Substances chimiques

Contrast Media 0

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1166-1181

Références

Eur J Gynaecol Oncol. 2012;33(6):672-4
pubmed: 23327071
Abdom Radiol (NY). 2018 Nov;43(11):3132-3141
pubmed: 29556691
Gynecol Oncol. 2016 Oct;143(1):93-97
pubmed: 27421754
Pediatr Radiol. 2018 Aug;48(9):1291-1306
pubmed: 30078037
Eur Radiol. 2017 Jun;27(6):2248-2257
pubmed: 27770228
Br J Radiol. 2015 Sep;88(1053):20150099
pubmed: 26083260
Magn Reson Imaging Clin N Am. 2017 Aug;25(3):521-543
pubmed: 28668158
Abdom Radiol (NY). 2018 Jul;43(7):1515-1523
pubmed: 29450608
J Magn Reson Imaging. 2019 Jun;49(6):1684-1693
pubmed: 30353967
Eur Radiol. 2010 Sep;20(9):2176-83
pubmed: 20419493
Eur Radiol. 2012 Apr;22(4):880-90
pubmed: 22095438
Insights Imaging. 2016 Feb;7(1):21-41
pubmed: 26671276
J Pediatr Adolesc Gynecol. 2014 Jun;27(3):125-8
pubmed: 24560684
Eur Radiol. 2019 Jul;29(7):3358-3371
pubmed: 30963272
J Ovarian Res. 2012 Nov 14;5(1):33
pubmed: 23148860
J Pediatr Adolesc Gynecol. 2017 Jun;30(3):405-412
pubmed: 28137453
Hum Reprod. 2016 Jun;31(6):1236-40
pubmed: 27067508
Radiographics. 2012 Oct;32(6):1751-73
pubmed: 23065168
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
J Magn Reson Imaging. 2017 Feb;45(2):418-427
pubmed: 27367786
Medicine (Baltimore). 2017 Jun;96(26):e7386
pubmed: 28658171
Radiographics. 2002 Nov-Dec;22(6):1305-25
pubmed: 12432104
BMJ Case Rep. 2014 Mar 31;2014:null
pubmed: 24686794
J Magn Reson Imaging. 2013 Feb;37(2):265-81
pubmed: 23355430
Eur Radiol. 2018 Nov;28(11):4849-4859
pubmed: 29737390
J Comput Assist Tomogr. 2010 Mar-Apr;34(2):173-6
pubmed: 20351498
Eur Radiol. 2008 May;18(5):1049-57
pubmed: 18193235
Ned Tijdschr Geneeskd. 2017;161:D967
pubmed: 28466797
J Obstet Gynaecol Can. 2011 Sep;33(9):935-43
pubmed: 21923991
Ultrasound Obstet Gynecol. 2008 Jun;31(6):681-90
pubmed: 18504770
Magn Reson Imaging Clin N Am. 2013 Nov;21(4):751-72
pubmed: 24183524
Tumour Biol. 2015 Jul;36(7):5515-22
pubmed: 25724182
Arch Iran Med. 2014 Sep;17(9):645-8
pubmed: 25204485
BMJ Case Rep. 2012 May 11;2012:null
pubmed: 22605874
Pediatr Radiol. 2011 Sep;41(9):1085-99
pubmed: 21567140
Radiology. 2000 Jan;214(1):39-46
pubmed: 10644099
J Pediatr Surg. 2014 Jan;49(1):144-7; discussion 147-8
pubmed: 24439599
Horm Res Paediatr. 2013;79(2):110-3
pubmed: 22832040
J Magn Reson Imaging. 2014 Jan;39(1):162-6
pubmed: 24123278
Invest Radiol. 2014 Aug;49(8):524-31
pubmed: 24637584
J Ovarian Res. 2018 Aug 30;11(1):73
pubmed: 30165895
Radiographics. 2014 Nov-Dec;34(7):2039-55
pubmed: 25384300
Arch Gynecol Obstet. 2014 Feb;289(2):357-64
pubmed: 23934242
Pediatr Rep. 2013 Jul 29;5(3):e13
pubmed: 24198925
Obstet Gynecol. 2012 Aug;120(2 Pt 2):473-6
pubmed: 22825270
J Pediatr Surg. 2018 Oct;53(10):2013-2018
pubmed: 29433795
J Ovarian Res. 2017 Jan 14;10(1):4
pubmed: 28088245
Eur Radiol. 2009 Jun;19(6):1544-52
pubmed: 19214523
Clin Chem. 2015 Dec;61(12):1446-52
pubmed: 26510957
Pediatr Radiol. 2016 Aug;46(9):1249-57
pubmed: 27097921
World J Surg Oncol. 2012 Nov 09;10:237
pubmed: 23137333
Korean J Pediatr. 2011 May;54(5):224-7
pubmed: 21829415
Pediatr Emerg Care. 2008 Aug;24(8):557-60
pubmed: 18708903
J Oncol. 2012;2012:481806
pubmed: 22536238

Auteurs

Lotte W E van Nimwegen (LWE)

Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584, CS, Utrecht, The Netherlands.

Annelies M C Mavinkurve-Groothuis (AMC)

Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584, CS, Utrecht, The Netherlands. a.m.c.mavinkurve-groothuis@prinsesmaximacentrum.nl.

Ronald R de Krijger (RR)

Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584, CS, Utrecht, The Netherlands.
Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.

Caroline C C Hulsker (CCC)

Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584, CS, Utrecht, The Netherlands.

Angelique J Goverde (AJ)

Department of Reproductive Medicine and Gynaecology, University Medical Center of Utrecht, Utrecht, The Netherlands.

József Zsiros (J)

Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584, CS, Utrecht, The Netherlands.

Annemieke S Littooij (AS)

Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584, CS, Utrecht, The Netherlands.
Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH